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Detection of recurrence of breast cancer after conserving breast surgery and radiotherapy
still represents a challenge because of changes in breast tissue after treatment. The aim was
to assess the value of Multislice CT mammography in the detection of recurrent breast can-
cer in patients with previous conservative surgery and radiotherapy. Subject and Methods:
The study included 126 consecutive patients with breast cancer treated with conservative
surgery and radiotherapy. CTM scans were evaluated by morphological and dynamic char-
acteristics. CTM diagnosis was compared with histology results. Results: MD-CTM findings
were compared with histology in 126 patients. CT mammography (CTM) showed 80% sen-
sitivity, 99% specificity, 97% positive predictive value and 92% negative predictive value for
detection of recurrence on the surgical.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Breast conservation therapy has gained acceptance as
treatment for limited disease due to breast cancer. Recur-
rence of breast cancer lesions on the surgical scar after
conservative surgery and radiation therapy has been
reported to occur in at least 1–2% of cases per year [1,2].
The proper follow-up of these patients usually includes
periodic clinical examination, mammography and ultra-
sonography [3]. Detection of recurrence on the priorlumpectomy site still represents a challenge because of
changes in breast tissue after treatment. Clinical examina-
tion, mammography or ultrasonography can raise a suspi-
cion but an additional evaluation is frequently mandatory
to avoid unnecessary biopsy or surgery [4].2. Purpose
The purpose of this study was to determine whether
dynamic CT mammography using 64-slice MDCT could
assist in differentiating between fibrotic postoperative scar
and cancer recurrence in patients underwent breast con-
serving surgery.3. Material and method
A prospective study was conducted after ethical com-
mittee approval.
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formed in 126 female patients with previous breast con-
serving surgery, having a fibrotic postoperative post
radiation indeterminate scar (classified as BIRADS 3 or 4
on mammography and ultrasonography).
3.1. The technique of radiotherapy
In the present study, the 3D conformal radiotherapy
plans consisted of two opposed tangential beams of 6–
10 MV energies. Patients are usually placed in the supine
position on an angled breast board with one or both arms
stretched above the head. The position of the patient is
kept similar in treatment and simulation. The patient is
placed on an angled breast board to correct the sloping of
the sternum. In addition to these tangential fields, regional
nodal irradiation is given when needed. Multi-leaf collima-
tion (MLC) was used to shield the heart and the lungs. 30–
45 degrees physical and dynamic wedges were used whenFig. 1. Patient position wiindicated. A total dose of 40–42.5 Gy in 5–10 fractions plus
a boost dose of 10–16 Gy in 4–8 fractions were used when
indicated (see Fig. 1).
3.2. The technique of MSCT
The optimal method for creating 3D-MDCT tumor
images was determined after the first 10 patients (learning
set). We used the state of the art 64-multidetector CT
(Aquilion)-Toshiba system.
 The patients were scanned in the prone position using
especially designed CT-compatible home-made fitting
device of cardboard and urethane sponges simulating
the MR-designed breast coils. The examination was per-
formed in 5 phases: first phase was a precontrast scan
to assess for microcalcification. Second phase was per-
formed after 30 s from the start of contrast injection
of a total amount of 100 ml non-iodinated contrast atthin the CT gantry.
Fig. 2. (a) Normal control case, 2D-MIP of 20 mm slab thickness was reconstructed. MPR reformatted axial, coronal and sagittal images were done and
assessed for the morphological criteria. (b) Time–density curve (kinetic data).
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1 min from the start of injection. The fourth phase
was performed after 3 min and the fifth phase was per-
formed 5 min from the start of contrast injection. The
images were taken with 1.25 mm section thickness
with a low radiation dose (kV 120 and mAS 80) in the
early cases (26 cases) but most cases were done using
80 kV and 50 mAS (100 cases). The calculated dose of
radiation is equivalent to bilateral 2 views mammogra-
phy. Three dimensional maximum intensity projection
(3d-MIP) of 20 mm slab thickness was reconstructed
and multi-planar (MPR) reformatted axial, coronal and
sagittal images were done showing the breast from
the nipple to the axilla, from the skin to the pectoral
muscle and chest wall. Time –density dynamic curve
was also done. In all cases sono-mammography was
available to review and compare with the CT mammog-
raphy results.
Histopathological confirmation of the diagnosis was
obtained in all cases via core biopsy, VAB or after open sur-
gical biopsy.4. CT data interpretation
The studies were analyzed in 2 ways (Fig. 2).Fig. 3. Examples of type of curves obtained from two different patients: Time–d
curve is a steep rapid rising slope reaching its peak within the first 3 min, and e
continuous slowly rising slope with no washout.
Table 1
Morphological criteria for evaluating CT mammography.
Qualitative analysis = architectural features
1. Radial density
2. Irregular density
3. Fat necrosis
4. Microcalcifications
5. Dystrophic calcifications
6. Egg-shell like calcification
7. Mass lesion
8. Mass like enhancement
9. Sector enhancement
10. Skin thickening
11. Architecture distortion
12. Remote lesion away from the scar
13. Contralateral breast lesion
Enlarged axillary lymph nodes4.1. First
Qualitative Analysis: it includes the architecture fea-
tures (Table 1) and the enhancement pattern (either duc-
tal, nodular, regional or mass like enhancement).
4.2. Second
Quantitative Analysis (kinetic data): it included the
evaluation of the time–intensity curves (Fig. 3) and mea-
surements of the peak enchantment and the peak enhance-
ment index (PEI).
The enhancement index was defined as the peak
enhancement of a lesion – its attenuation value in the
non contrast phase measured in HU, for example, if the
maximal enhancement was 120 HU and the CT attenuation
in the non-contrast was 66 HU, so that the enhancement
index will be 120–66 = 54 HU (see Figs. 4 and 5).5. Diagnosis
We followed the Breast Imaging Reporting and Data
System (BIRADS) described by ACR, 1998, to diagnose the
likelihood of breast cancer based on the criteria of the
lesion obtained from the study done (mammography and
ultrasound) [5] Table 2.6. Statistical analysis
For statistical analysis, a software package (Excel 2000;
Microsoft, Redmond, Wash) was used.7. Results
The study was conducted to 126 female patients with
postoperative indeterminate scar seen by mammography
and ultrasonography. Their age ranged between 35 and
65 yrs and the mean age was 45 ± 3.1. In all cases sono-
mammography was available for review and histopatholo-
gical confirmation was obtained after biopsy (FNB, CNB or
OB). We found 71.44% (90 cases) malignant lesions and
28.55% (36 cases) benign findings. The following table
(Table 1) is the histopathological diagnosis of our study
group. The results are demonstrated in Tables 3–8.ensity curves, to the right hand side, the typical pattern for a malignant
xhibiting washout [16]. To the left hand side,the benign curve, it shows a
Fig. 4. 65 yrs old with CBS 4 yrs ago, (a) an irregular lesion was seen at the site of the postoperative scar in mammography on routine follow-up. (b) It appeared as
a solid hypoechoic lesion by ultrasound. By CTM (c): an enhancing irregular shaped lesion was detected, (d) the kinetic criteria obtained from the curve indicate a
benign lesion and the LEI was 13 HU (speaks against malignancy). CNB: Fibrotic scar on histopathology, (e) pleural asbestosis calcified plaques are also seen.
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Fig. 4 (continued)
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Fig. 5. 54 yrs old female with history of left lumpectomy 1 year ago, presented with a palpable lump at the site of previous surgery in the left UIQ. (a)
Mammography and (b) US confirmed the presence of a large malignant looking mass (BIRADS 5). (c) CTM added the evidences of invasion of the pectoralis
muscle. (d) The kinetic criteria obtained from the curve (rapid washout) and the LEI (82 HU) were diagnostic of malignancy, and proved by histopathology
(high grade IDC) after core needle biopsy.
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Fig. 5 (continued)
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follows: sensitivity 91.6%, specificity 25%, negative predic-
tive value 25%, positive predictive value 97.05% and the
overall accuracy 89.47%.Table 2
Understanding BIRADS Scores.
Category Diagnosis Number of criteria
0 Incomplete The study didn’t give the radiolog
necessary
1 Negative There is nothing to comment on;
2 Benign A definite benign finding; routine
3 Probably benign Findings that have a high probab
4 Suspicious abnormality Not characteristic of breast cancer
be considered
5 Highly suspicious of
malignancy
Lesion that has a high probability
6 Known biopsy proven
malignancy
Lesions known to be malignant th
is completedThe accuracy measures of high enhancement (>100 HU)
are as follows: sensitivity 77.7%, specificity 100%, negative
predictive value 91.8%, positive predictive value 100% and
the overall accuracy 92.18%.ist enough information to make a clear diagnosis; follow-up imaging is
routine screening recommended
screening recommended
ility of being benign (>98%); six-month short interval follow-up
, but reasonable probability of being malignant (3–94%); biopsy should
of being malignant (>= 95%); take appropriate action
at are being imaged prior to definitive treatment; assure that treatment
Table 3
The histopathological diagnosis of the study group.
Histopathological diagnosis No. of
cases
Relative
frequency (%)
Benign scar 30 23.8
Fat necrosis 28 22.2
Seroma 17 13.49
Fat inclusion in a scar 12 9.52
Necrobiotic xanthogranulomatosis 2 1.58
Inflammatory lesion 7 5.5
Invasive duct carcinoma 12 9.52
Invasive lobular carcinoma 6 4.76
Medullary carcinoma 3 2.38
Lobular carcinoma 4 3.16
Tubular carcinoma 2 1.58
Papillary carcinoma 2 1.58
Paget’s carcinoma 1 0.79
Total 126 100%
N. Abdel Razek, A.E. Essa / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1709–1720 1717The accuracy measures of moderate enhancement (45–
100 HU) are as follows: sensitivity 16.6%, specificity 61%,
negative predictive value 50%, positive predictive value
11.3% and the overall accuracy 39.8%.
The accuracy measures of low enhancement (<45 HU)
are as follows: sensitivity 0.05%, specificity 50%, negative
predictive value 55.8%, positive predictive value 0.04%
and the overall accuracy 36%.
The enhancement index was defined as the peak
enhancement of a lesion – its attenuation value in the
non contrast phase measured in HU.
Example: If the maximal enhancement was 120 HU and
the CT attenuation in the non-contrast was 66 HU, so that
the enhancement index will be 120–66 = 54 HU.
The LEI in malignant lesions was 57 HU ± 11 HU and
that for benign lesions was 13 HU ± 2 HU and the differ-Table 4
Imaging findings of CT mammography.
CT findings No. of
cases
Radial density 25
Anti-radial density 35
Irregular density 101
Fat inclusion 45
Microcalcification 15
Dystrophic calcification 26
Egg-shell like calcification 14
Mass like enhancement 81
Non mass enhancement 45
Skin thickening 45
Parenchymal edema 23
Architecture distortion 45
Pectoral involvement 2
Early washout sign 34
Plateau pattern 14
Persist rise in curve 78
Enlarged axillary lymph nodes 12
Lesions remote from the scar 15
Breast cellulitis 14
Contra-lateral breast lesion 23
Extra-mammary additional information
(chest disease, pulmonary deposits, rib
lesion, vascular or mediastinal problem)
17ence between them was statistically significant (P
value < 0.001).
When the cutoff value was chosen at 25 HU, all lesions
(100%) with PEI above 25 HU were pathologically proven
as malignant recurrence (100% sensitivity and 100% nega-
tive PV), as a very sensitive indicator of malignancy.
When the cutoff value was chosen below 15 HU, most
of the lesions (97.6%) were pathologically proven as benign
scars and few (2.4%) were malignant with 97.6% sensitivity
and 100% negative PV as an indicator of benignity.
When the cutoff value was chosen between 15 and 25
HU, we have found that 46.1% were malignant and 53.9%
were benign. The difference is statistically not significant.
So we have considered this zone as the gray zone (negative
PV is 50%) (see Table 9).8. Discussion
Our study is a prospective study done to evaluate the
role of CT mammography in assessment of the postopera-
tive and post-radiation changes after conserving breast
surgery. It is now well accepted that local tumor recur-
rences after breast-conserving therapy do influence a
patient’s prognosis because they may cause distant metas-
tases just as primary breast cancer does. Therefore, any
attempt to improve early diagnosis of tumor recurrence
seems justified to further improve the patient’s outcome
[6,7]. However, after breast-conserving therapy, post-
therapeutic changes may interfere with an accurate inter-
pretation of clinical examination findings, as well as of
conventional imaging studies. Interpretation of post-
therapeutic mammograms may be impaired due to a dif-
fusely increased density of the breast parenchyma (edemaPercentage Breast
cancer
Prevalence
in breast
cancer
19.84 1 0.4
27.7 12 48
80.15 89 88.1
35.7 0 0
11.9 10 66.6
20.6 0 0
11.11 0 0
64.2 67 82.7
35.7 30 66.6
35.7 29 64.4
18.25 13 56.5
35.7 24 53.3
1.5 2 100
26.9 33 97
11.1 3 21.4
61.9 0 0
9.5 10 83.3
11.9 15 100
11.11 9 64.2
18.25 23 100
13.5 8 47
Table 8
Accuracy measures of conventional mammography, sono-mammography and MD
Histopathological diagnosis Conventional mammogr
Benign 90(71.44) 101(80.2)
Malignant 36(28.55) 25(19.8)
Total 126(100) 126(100)
Item Malignant TP
Conventional mammography 25 15
Sono-mammography 28 23
MD-Ct mammography 34 33
The following parameter for conventional mammography in comparison with h
Sensitivity: 0.59 [0.36, 61.00]
Specificity: 0.28 [0.19, 0.38]
Accuracy: 0.48 [0.39, 0.57]
Predictive value of +ve result: 0.36 [0.27, 0.46]
Predictive value of ve result: 1.00 [0.83, 1.00]
While the parameter for sono-mammography in comparison with histopatholog
Sensitivity: 0.78 [0.60, 0.89]
Specificity: 1.00 [0.95, 1.00]
Accuracy: 0.94 [0.87, 0.97]
Predictive value of +ve result: 1.00 [0.85, 1.00]
Predictive value of ve result: 0.92 [0.84, 0.9]
While the parameter for MD-CT in comparison with histopathology:
Sensitivity: 0.94 [0.80, 0.99]
Specificity: 1.00 [0.95, 1.00]
Accuracy: 0.98 [0.94, 1.00]
Predictive value of +ve result: 1.00 [0.87, 1.00]
Predictive value of ve result: 0.98 [0.92, 1.00]
From this we notice that high sensitivity and specificity were for MD CT follow
mammography.
Table 5
Accuracy measures of the dynamic curve pattern as a predictor of
malignancy in postoperative breast.
Type of curve No. of cases True benign True malignant
Rapid washout 34 1 33
Plateau 14 13 3
Delayed washout 78 76 0
Total 126 90 36
Table 6
Accuracy measures of the enhancement peak as a predictor of malignancy
in postoperative breast.
Type of curve No. of
cases
True
benign
True
malignant
High enhancement (>100 HU) 28 0 28
Moderate enhancement
(45–100 HU)
53 47 6
Low enhancement (<45 HU) 45 43 2
Total 126 90 36
Table 7
Accuracy measures of the enhancement index as a predictor of malignancy
in postoperative breast.
PEI No. of cases True benign True malignant
(>25 HU) 28 0 28
(15–25 HU) 13 7 6
(<15 HU) 85 83 2
Total 126 90 36
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radiation therapy). As many as 19–45% of all recurrences
are invisible or misinterpreted on mammograms obtained
after radiation therapy [8]. On the other hand, architectural
distortion owing to scarring, dystrophic calcifications, and
stellate or mass-like lesions may mimic tumor recurrence
and may cause diagnostic difficulties and unnecessary
biopsies. High-frequency breast US may be problematic
after breast-conserving therapy as well, because diffuse
acoustic shadowing owing to scarring can mimic or
obscure tumor recurrence [9].
Use of breast MR imaging is well accepted to improve
differentiation of scar versus tumor recurrence when it is
performed later than 12–18 months after the end of radia-
tion therapy [9].
CT is usually not the first modality to be used in imaging
breast cancer, but it may be used as an adjuvant for mon-
itoring spread. Although it involves some exposure to radi-
ation, it should be considered in patients in whom MRI is
contraindicated [10]. Three-dimensional (3D) helical CT
can provide good information about the spread of breast
cancer and could be an alternative to 3D MRI for
preoperative examination of breast cancer [11]. In vitro
high-resolution helical CT can depict the internal structure
of small nodes. Morphologic changes detected on helical
CT help distinguish benign from malignant nodes. Tumors
appear as dense lesions on CT and usually show early con-
trast enhancement similar to that seen with dynamic MRI
[12]. CT is less sensitive than mammography for detecting
microcalcification when it is the sole manifestation of early
cancer [13].-CT mammography in diagnosis of scar carcinoma.
aphy Sono-mammography MD-CT mammography
98(77.7) 92(73.1)
28(22.2) 34(29.9)
126(100) 126(100)
FP Benign TN FN
10 101 80 21
5 98 90 8
1 92 90 2
istopathology:
y:
ed by sono-mammography and the lowest in specificity is conventional
Table 9
Comparison between the accuracy measures of conventional mammography, sono-mammography and MD-CT
mammography in the diagnosis of scar carcinoma.
Conventional
mammography
(%)
Sono-
mammography
(%)
MD-CT
mammography
(%)
Sensitivity 42 74 80
Specificity 89 95 99
Positive predictive value 60 82 97
Negative predictive value 79 92 92
Accuracy 75 90 93
Conventional mammography:
Screening [95% CI]
Prevalence: 0.29 [0.21, 0.37]
Sensitivity: 0.42 [0.26, 0.59]
Specificity: 0.89 [0.80, 0.94]
Accuracy: 0.75 [0.67, 0.82]
Predictive value of +ve result: 0.60 [0.39, 0.78]
Predictive value of ve result: 0.79 [0.70, 0.86]
Sono-mammography:
Screening [95% CI]
Prevalence: 0.25 [0.18, 0.33]
Sensitivity: 0.74 [0.55, 0.87]
Specificity: 0.95 [0.88, 0.98]
Accuracy: 0.90 [0.83, 0.94]
Predictive value of +ve result: 0.82 [0.62, 0.93]
Predictive value of ve result: 0.92 [0.84, 0.9]
CT mammography:
Screening [95% CI]
Prevalence: 0.31 [0.23, 0.40]
Sensitivity: 0.80 [0.65, 0.91]
Specificity: 0.99 [0.93, 1.00]
Accuracy: 0.93 [0.87, 0.97]
Predictive value of +ve result: 0.97 [0.83, 1.00]
Predictive value of ve result: 0.92 [0.84, 0.96].
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mammography of the breasts as a unique method in diag-
nosis of breast cancer recurrence on top of a scar after
breast conserving surgery. We have followed the breast
CT lexicon based on the MRI as our references concerning
the morphological and kinetic data analysis [14,15].
In terms of morphological descriptors in our study, the
positive predictive value of mass like enhancement for
malignancy was 82.7% compared to 66.6% in non-mass like
enhancement. The frequency of malignancy in speculated
irregular density was 88.1% and in the presence of archi-
tecture distortion, it was 53.3%. These results are consis-
tent with the previously published reports [8,14].
Our data obtained from the kinetic analysis confirm
data of previous Breast MRI studies [9,10,16,17]. In our
study, rapid washout sign was a sensitive indicator of
malignancy with a sensitivity of 91.6%, specificity of
25%, negative predictive value of 25%, positive predictive
value of 97.05% and the overall accuracy of 89.47%. The
high enhancement (>100 HU) is also another sensitive
measure of malignancy with a sensitivity of 77.7%, speci-
ficity of 100%, negative predictive value of 91.8%, positive
predictive value of 100% and the overall accuracy of
92.18%.
This study is the first to describe the enhancement
index in differentiating benign from malignant breast
lesions. The enhancement index is defined as the peak
enhancement of a lesion – its attenuation value in the
non contrast phase measured in HU. So for example, ifthe maximal enhancement was 120 HU and the CT attenu-
ation in the non-contrast was 66 HU, so that the enhance-
ment index will be 120–66 = 54 HU. The LEI in malignant
lesions was 57 HU ± 11 HU and that for benign lesions
was 13 HU ± 2 HU and the difference between them was
statistically significant (P value < 0.001). When the cutoff
value was chosen at 25 HU, all lesions (100%) with PEI
above 25 HU were pathologically proven as malignant
recurrence (100% sensitivity and 100% negative PV).
Accordingly, it was considered as a very sensitive indicator
of malignancy.
When the cutoff value was chosen below 15 HU, most
of the lesions (97.6%) were pathologically proven as benign
scars and few (2.4%) were malignant with 97.6% sensitivity
and 100% negative PV as an indicator of benignity. When
the cutoff value was chosen between 15 and 25 HU, we
have found that 46.1% were malignant and 53.9% were
benign. The difference is statistically not significant. So
we have considered this zone as the gray zone (negative
PV is 50%).
For the detection of recurrence of breast cancer on top
of a scar, we have found that MDCT to be superior to mam-
mography and sonography together. The incidence of
breast cancer recurrence among our patients was 28.5%.
CT mammography (CTM) showed 80% sensitivity, 99%
specificity, 97% positive predictive value and 92% negative
predictive value for detection of recurrence on the surgical
scar. The overall accuracy of CTM for detection of breast
malignancy on top of a scar was 93%, compared to overall
1720 N. Abdel Razek, A.E. Essa / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1709–1720accuracy of 75% and 90% by conventional mammography
and sono-mammography respectively.
Moreover, it was superior to the conventional methods
in detecting lesions remote from the scar, contralateral
breast lesions and pectoral and chest wall invasion. CT-
mammography detected lesions remote from the scar in
11.9% of cases and detected contra-lateral breast lesions
in 18.25% of cases. Also extra-mammary information in
the chest and axillae was available by MD-CTM in 13.5%
of cases.
In previous studies done to assess the performance of
3D CT in detection of breast cancer and diagnosis of tumor
extension, CT was able to diagnose all tumors. Its sensitiv-
ity, specificity, and accuracy in diagnosing muscular inva-
sion of breast cancer were 100%, 99%, and 99%,
respectively. Its sensitivity, specificity, and accuracy in
diagnosing skin invasion of breast cancer were 84%, 93%,
and 91%, respectively. The sensitivity, specificity, and accu-
racy in detecting intraductal spread or DCIS were 71.9%,
83.3%, and 76.0%, respectively, for 3D CT and 87.5%,
61.1%, and 78.0%, respectively, for 3D MRI. The sensitivity
rate for microcalcifications was about 59% [13,18].
MR mammography is reported to be more accurate
than mammographyand US in detecting carcinoma after
conservative breast surgery [8,9]. In our study, we did
not compare CTM and MRM, but in a previous comparing
CTM and MRM, CT was found to perform almost as well
as MRI in detecting breast cancer [11]. Moreover, MDCT
mammography has several advantages over MRM. With
MDCT, the breast is scanned faster, with thinner collima-
tion and with the examination can be done in the prone
and supine position. Moreover it allows examination of
the chest and axillae simultaneously [14].
One of the disadvantages of MDCT is the exposure to
radiation; however, this problem might not be a serious
problem for patients who are thought to have breast can-
cer [14]. Moreover these patients already scheduled for
CT chest for metastatic work up and we can combine the
study of the chest and breast in one scan.
In this study we tried two X-ray doses (120 kV and
80 mAs) and (80 kV and 50 mAs), and there was a signifi-
cant reduction to the X-ray exposure to the skin per rota-
tion of the tube (26 mGy and 18 mGy) respectively. In a
published research based on a validated Monte–Carlo sim-
ulation technique to estimate the average glandular dose
(AGD), for a kV 80 breast CT, it was found that the dose
was comparable to the two view mammography [19].
CT mammography can be very helpful in evaluation of
post-operative and post radiation changes after conserving
breast surgery and considered as good as MRI especially
when MRI is contraindicated, unavailable or cannot be tol-
erated by some patients.
8. Conclusion
Dynamic Multislice CT mammography is a good adjunct
imaging in postoperative patients after breast salvage surgerywith questionable scar helping to differentiate between fibrotic
scar following surgery and radiation and cancer recurrence.Conflict of interest
None declared.
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